No description available.

Elucidating the mechanisms responsible for driving individual variation in behavior is a foundational question in organismal biology. Answering these types of questions is necessary for understanding how tradeoffs are mediated as well as potential constraints on evolutionary responses to selection. In Chapter I, I synthesize the evidence suggesting that testosterone plays a central role in driving individual variation in cooperative reproductive behaviors and mediating the tradeoff between cooperation and competition. The subsequent chapters of my dissertation then focus on understanding the mechanistic sources of individual variation in the cooperative courtship behaviors of male wire-tailed manakins (Pipra filicauda), a Neotropical lekking songbird. Wire-tailed manakins exhibit cooperative courtship display behaviors wherein both floater and territory-holding males perform coordinated courtship displays. Territory-holding males sire essentially all offspring and, among territory-holders, those that are more cooperative exhibit higher reproductive success. Cooperation also benefits floater males in that more cooperative floater males have a higher probability of becoming a territory-holder. In Chapter II, I detail the difficulties associated with measuring circulating testosterone in free-living animals and develop a new field technique that can improve our ability to accurately account for the effects that the stress of capture has on circulating testosterone levels in birds. In Chapter III, I quantify individual variation in the cooperative courtship behaviors of territory-holding male wire-tailed manakins using video cameras. I then use both observational and experimental approaches to show that among territory holders, high testosterone has antagonistic effects on a male's cooperative behavior. Chapter IV focuses on quantifying how an individual's cooperative behavior relates to their telomere length. Telomeres are the segments of repetitive DNA found at the end of chromosomes. Telomeres shorten in response to both physiological and environmental perturbations, are predictive of an individual's mortality risk and, because of these characteristics, are thought to reflect an individual's biological age (as opposed to chronological age). My results show that short telomeres are associated with increased cooperative behaviors and, given that a male's cooperative behavior is reflective of their reproductive investment, suggest that males with lower future reproductive potential (i.e., shorter telomeres) invest more in reproduction. My last chapter (Chapter V) focuses on synthesizing these results and suggests that future research on cooperative behaviors will need to integrate biomarkers of an individual's condition with mechanisms that reflect an individual's social competence to further understand the sources of individual variation in cooperation. / Doctor of Philosophy / Cooperative reproductive behaviors occur when multiple individuals coordinate their reproductive efforts to gain an advantage over other individuals or those individuals that attempt to reproduce in the absence of cooperation. In this context, some individuals have been found to consistently act more or less cooperative, and outstanding questions regarding the evolution of cooperative reproductive behaviors focus on attempting to understand the intrinsic differences among individuals that consistently vary in their cooperative tendencies. In this dissertation, I focus on measuring individual variation in the cooperative reproductive behavior of male wire-tailed manakins, a passerine found in the Amazon Rainforest, as well as the sources of this individual variation. Male wire-tailed manakins perform acrobatic courtship displays for females. Wire-tailed manakins are especially interesting in that multiple males will perform coordinated courtship displays, but only one male within the group typically reproduces. Individual variation in this cooperative behavior also influences how likely an individual is to reproduce. Chapter I synthesizes the evidence across species to suggest that testosterone, a hormone known for influencing competitive reproductive behaviors, influences an individual’s likelihood of acting in a cooperative or competitive manner. Chapter II describes the difficulties associated with measuring circulating testosterone in wild animals and describes techniques that can be used to overcome some of the difficulties associated with measuring circulating testosterone in free-living birds. Chapter III focuses on understanding the relationship between testosterone and individual differences in the cooperative reproductive behaviors of the wire-tailed manakin. I find that those males with higher testosterone or those with experimentally increased testosterone are less cooperative. I discuss my results in the context of understanding how this relationship could influence the evolution of circulating testosterone levels more broadly. Chapter IV examines the relationship between the cooperative reproductive behavior of male wire-tailed manakins and the repetitive segments of DNA found at the end of chromosomes called telomeres. Telomeres shorten as individuals age and the length of an individual’s telomeres has been found to be predictive of their lifespan and mortality risk. My research shows that those individuals with shorter telomeres (or a higher mortality risk) are more cooperative. Given that an individual’s cooperative behavior is predictive of their probability of successfully reproducing, my research suggests that those individuals that are more likely to perish invest more time and energy in attempting to reproduce. In Chapter V, I conclude by summarizing my results and suggesting future research that can further our understanding of the sources of consistent individual differences in cooperative behavior and the evolution of cooperation more broadly.

En hématologie, du fait de leur évolution favorable, les tumeurs spontanément regressives comme lesmodèles myéloïde de la mastocytose, et lymphoïde de la papulose lymphomatoïde sont peu étudiés. Lamastocytose est une hémopathie myéloproliférative clonale dont les lésions cutanées peuvent régresserspontanément chez l’enfant alors que la maladie est chronique chez l’adulte. Les mutations chezl’enfant sont en partie différentes de celles retrouvées chez l’adulte. Nous avons montré in vivo dansles mastocytoses pédiatriques une expression diminuée de la télomérase, associée à des télomèrescourts. In vitro, grâce à deux modèles cellulaires comportant différents mutants de KIT de « typepédiatriques » ou de « type adulte », nous avons montré une augmentation de la longueur destélomères dans le mutant adulte, associée à une moindre sénescence comparées aux mutantspédiatriques sans pour autant mettre en évidence de différence dans l’expression et l’activité de latélomérase. Ces observations permettent en partie d’expliquer la régression des formes pédiatriques.La papulose lymphomatoïde est une lymphoprolifération cutanée T CD30+ dont les lésions régressentspontanément sans traitement. Cependant 10 à 20% des cas sont associés à un lymphome. Nous avonsétudié la physiopathologie d’expression du PDGFRβ dans les cellules tumorales via l’activation deNotch1. L’étude des télomères et de la télomérase in vivo et in vitro est préliminaire, et montrenotamment des télomères courts dans les cellules tumorales. En conclusion, nous montrons d’une partque la longueur des télomères dans les mastocytoses et la papulose lymphomatoïde est corrélée àl’évolution de la maladie, d’autre part, nous identifions un type de mutation potentiellement agressivedans les mastocytoses. Nous recommandons le génotypage systématique de cette pathologie dans lebut d’un suivi clinique attentif lorsque les lésions sont persistantes ou évolutives. / Childhood mastocytosis and lymphomatoid papulosis are mostly spontaneously regressive diseases.Mastocytosis is a clonal myeloproliferative disease; whereas cutaneous forms may regressspontaneously especially in childhood, the disease is chronic among adults. KIT mutations aredifferent between children and adults. We showed in vivo that children with mastocytosis displaydecreased telomerase expression with shorter telomere length. In vitro, using infected cells withdifferent KIT mutants, "paediatric" or "adult " one, we found longer telomere among adult mutant withdecreased senescence compared to paediatric mutant, without significant differences of telomeraseexpression and activity. These observations could explain the regression in paediatric mastocytosis.Lymphomatoid papulosis is a primary cutaneous CD30+ T-cell lymphoproliferative disorder.Cutaneous lesions are spontaneously regressive but association with a T-cell lymphoma is observed in10 to 20% of cases. We studied PDGFRβ expression to explain proliferative phase and telomerebiology to understand the regressive phase of the disease. Our result showed that PDGFRβ expressionin CD30+ cells was associated to short telomeres. In conclusion, we showed for the first time thattelomere length in mastocytosis and lymphomatoid papulosis seemed to be correlated with diseaseoutcome; on the other hand, we identify a mutation potentially aggressive. Taken together, werecommend to systematically look for KIT mutation among each patient with mastocytosis in order tocarefully monitor them when the cutaneous lesions are persistent and/or progressive.

Des mutations dans ATRX, une protéine de remodelage de la chromatine, ont été associées, dans plusieurs études cliniques, avec la voie télomérase-indépendante de maintenance des télomères (voie ALT) dans plusieurs types de cancer. Grâce à des expériences d’immunoprécipitation de chromatine (ChIP), nous avons montré qu’ATRX était localisée au niveau subtélomérique de cellules tumorales humaines en culture. Nous avons également montré, par ChIP, que l’inactivation génétique d’ATRX provoquait une diminution des quantités de cohésine/SMC1 présentes dans les régions subtélomériques. L’inactivation d’ATRX a conduit en outre à une diminution des quantités de TERRA, transcrits non codants de l’ADN télomérique. Nos données suggèrent qu’ATRX pourrait établir des interactions fonctionnelles avec la cohésine au niveau de la chromatine subtelomérique afin de contrôler les niveaux de TERRA et que l’un ou l’autre de ces évènements pourrait avoir un rapport avec la voie ALT. / Mutations in ATRX, a chromatin remodeling protein, have been found, in several clinical studies, associated with the telomerase-independent ALT pathway of telomere maintenance in several types of cancer. Using chromatin immunoprecipitation (ChIP), we have shown that ATRX localized to subtelomeric regions of human tumor cells in culture. Cohesin has recently been shown to be part of telomeric chromatin. Here, using ChIP, we showed that genetic inactivation of ATRX provoked a diminution in the amount of cohesin in subtelomeric regions of telomerase-positive glioma cells. Moreover, inactivation of ATRX also led to a diminution in the amount of TERRAs, non-coding RNAs resulting from transcription of telomeric DNA. Our data suggest that ATRX might establish functional interactions with cohesin on subtelomeric chromatin in order to control TERRA levels and that one or the other or both of these events might be important for ALT mechanisms.

Mammalian telomeres are nucleoprotein complexes at the end of chromosomes containing a specific protein complex, called shelterin. Shelterin protects chromosome ends from the DNA damage response (DDR), by facilitating the formation of a telomeric capping structure, called the T-loop. During their elongation in S phase, telomeres become transiently uncapped and can be sensed as DNA damage in G2 phase. This leads to the recruitment of DDR factors, such as phosphorylated histone H2AX (γH2AX), to the telomeres forming the so-called, telomere dysfunction-induced foci (TIFs). My PhD work described here, indicates that DNA damage occurring during interphase can persist after entry into mitosis, indicated by the detection of γH2AX at a subset of mitotic telomeres in human and mouse cells. This accumulation of γH2AX to mitotic telomeres is ATM-dependent and the γH2AX-labelled uncapped telomeres that persist, are shorter than the average telomere length for the entire cell population. Most importantly, my work suggests that telomere uncapping, naturally occurring or artificially induced, is detected by two parallel ATM/ATR-dependent pathways at the G2/M transition: a p53/p21-dependent pathway through the ATM/ATR-mediated phosphorylation of p53 at Ser15 and a CHK1/CHK2-dependent pathway that acts through negative regulation of CDC25 phosphatases. In particular, telomere uncapping triggered by TRF2 depletion leads to CHK2-dependent CDC25A degradation, while POT1 depletion results in CHK1-mediated CDC25A and CDC25C degradation. Both pathways act as sensors of unprotected telomeres at the G2/M transition and block cell cycle progression through inhibition of CDK1/Cyclin B complex, allowing telomere re-capping before entry into mitosis. This mechanism protects telomere integrity by the maintenance of a cell cycle stage conducive for capping reactions and thereby prevents genomic instability induced by telomere dysfunction. Finally, I studied the cellular functions of 3 poorly characterised shelterin components, TRF1, RAP1 and TPP1, in telomere protection. TRF1 and to a lesser extent RAP1 were shown to be important for telomere protection by suppressing DDR at the telomeres, while TPP1 was shown to be mainly responsible for the recruitment of the catalytic subunit of telomerase, TERT , to the chromatin, contributing to telomere maintenance. In conclusion, my work on both human and mouse models, reveals an important part of the DDR pathways activated by dysfunctional telomeres, as well as the molecular mechanisms underlying the cell cycle specific regulation of telomere capping, which ensures that only cells with intact telomeres enter mitosis.

L'immortalité cellulaire est toujours accompagnée par l'activation du mécanisme de maintien des télomères. Dans la plupart des cancers humains, ce rôle est assuré par l'enzyme télomérase. Cependant, dans 15 % des tumeurs, la télomérase n'est pas activée et les télomères sont maintenus par l'allongement alternatif des télomères (ALT), voie qui implique la recombinaison des télomères. ALT est plus fréquent dans les tumeurs provenant de tissus mésenchymateux (sarcomes), representant 40-60 % des cas, que dans les tumeurs épithéliales. Comprendre le mécanisme ALT est primordial dans les thérapies anti-cancéreuses puisque certaines drogues inhibant la télomérase conduisent souvent à l'activation de l'ALT.La voie ALT est définie par de caractéristiques typiques des télomères. Dans les cellules ALT, les recombinaisons aberrantes d'ADN ne se limitent pas aux télomères puisque les génomes sont souvent fortement réarrangés. Les liens de ces caractéristiques génomiques anormales et la maintenance des télomères atypique ne sont pas connues, mais l'instabilité du génome contribue certainement à la transformation. Notre équipe a montré que les récepteurs orphelins appartenant aux familles NR2C/F ont été trouvés enrichies dans les télomères des lignées cellulaires ALT. Nous avons proposé que ces facteurs puissent être recrutés aux télomères par liaison directe à la séquence répétée GGGTCA, un site de liaison à haute affinité pour ces protéines. Mon projet vise à comprendre (i) leur mécanisme de liaison et (ii) leur rôle, dans le processus d'ALT.Dans cette étude nous montrons que dans les sarcomes primaires humains, les télomères d'ALT sont souvent liés par des récepteurs nucléaires orphelins des sous-familles NR2C/F, en particulier dans les tumeurs au stade avancé. Ceci suggère un rôle actif de ces facteurs dans la progression tumorale ALT. En utilisant la technique de ChIP-sequencing, nous avons montré que les protéines NR2C/F se lient à une répétition directe amplifiée (DR0) aux télomères, et pas de manière significative à toute autre combinaison de motif GGGTCA. Nous avons également analysé la distribution sur tout le génome de NR2C2/F2 et TRF2, une protéine de liaison des télomères, dans des cellules ALT (-) et ALT (+). Bien qu'il n'y ait que peu de sites génomiques liés par TRF2 dans les cellules ALT (-), nous avons été surpris d'identifier plusieurs centaines de régions liées par TRF2 dans les cellules ALT (+). Plus surprenant, la grande majorité de ces régions spécifiques TRF2 ALT chevauche des sites endogènes de NR2C2/F2. Étant donné que ces sites ne contiennent généralement pas les répétitions des télomères, TRF2 est probablement recruté de façon indirecte. Conformément à cette interprétation, nous montrons que les facteurs NR2C/F entrainent un rapprochement des loci et sont responsables du regroupement atypique des télomeres dans ALT. De plus, un sous-ensemble de ces régions génomiques uniques a des additions hétérogènes des séquences télomeriques ALT, suggérant un rôle dans le recrutement des télomères par des protéines NR2C/F mais aussi une fonction de ciblage de recombinaison génomique. Systématiquement, nous trouvons que ces réarrangements des télomères/génome sont situés à proximité des motifs GGGTCA endogènes. Le caryotype spectral des lignées cellulaires ATL montre que les sites télomériques interstitielles sont fréquemment localisés aux niveaux des sites de translocations/réarrangements entre deux ou plusieurs chromosomes, ce qui est également observé dans les données de ChIPseq. Ces résultats suggèrent que les réarrangements entres les télomères et le génome pourraient participer à la formation d'un caryotype complexe ce qui caractérise environ 50% des sarcomes. De plus, l'addition de sites télomériques interstitielles dans le génome est spécifique des cellules ALT et est favorisée par les dommages de l'ADN. / Cellular immortality is always accompanied by the activation of telomere maintenance mechanism. In most human cancers this role is fulfilled by the telomerase enzyme. However in 15% of tumors, telomerase is not activated and telomeres are maintained by an Alternative Lengthening of Telomeres (ALT) pathway that involves telomere-telomere recombination. Interestingly ALT is more prevalent in tumors originating from mesenchymal tissues (sarcomas), where it is present in 40-60% of cases, than in epithelial tumors. Understanding ALT maintenance is critical since inhibiting telomerase in tumors leads to the activation of ALT. The ALT pathway is operationally defined by typical telomere hallmarks. In ALT cells, aberrant DNA transactions are not restricted to telomeres since genomes are often highly rearranged. Whether these abnormal genomic features are linked to atypical telomere maintenance is not known, but genome instability is certainly contributing to transformation. We have previously shown that orphan receptors of the NR2C/F families were enriched at telomeres in ALT cell lines. We proposed that these factors could be recruited to telomeres through direct binding to the GGGTCA variant repeat, a high affinity binding site for these proteins. My project is aimed at understanding (i) their mechanism of binding and (ii) their role, if any, in the ALT process.We show that in human primary sarcomas, ALT telomeres are often bound by orphan nuclear receptors of the NR2C/F subfamilies, particularly in more advanced-stage tumors. This suggests an active role for these factors in ALT tumor progression. Using ChIP-sequencing, we show that NR2C/F proteins bind to an amplified direct repeat (DR0) at telomeres, and not significantly to any other GGGTCA motif combination. We also analyzed the genome wide distribution of NR2C2/F2 and TRF2, a telomere binding protein, in ALT(-) and in ALT(+) cells. While there are only few genomic sites bound by TRF2 in ALT(-) cells, we were surprised to identify several hundred regions bound by TRF2 in ALT(+) cells. More surprisingly, the great majority of these ALT specific TRF2 regions overlap with endogenous NR2C2/F2 sites. Since these sites usually do not contain telomere repeats, TRF2 is likely indirectly recruited. Consistent with this interpretation, we show that NR2C/F factors drive locus proximity. Moreover, a subset of these unique genomic regions harbor heterogeneous ALT telomere sequence additions, not only suggesting a telomere recruitment role for NR2C/F proteins but also a recombination targeting function in the genome. Consistently, we find these telomere/genome rearrangements are located close to endogenous GGGTCA motifs. Next, we wanted to evaluate a role of these rearrangements in formation of complex karyotype which characterize approximately 50% of sarcomas. We found by spectral karyotyping that interstitial telomeric sites are frequently located at translocation/ rearrangements sites between two or more chromosomes, which we could also observe in our ChIPseq data. Furthermore, we demonstrate that addition of interstitial telomeric sites to the genome is enhanced by DNA damage and specific for ALT genome. Therefore we conclude that NR2C/F factors target telomere proximity to defined NR2C/F regions which enables telomere-genome rearrangements under DNA damage condition. This contributes not only to efficient telomere recombination, but also it drives further genomic instability at selected NR2C/F sites.We believe we identified a new mechanism of telomere dysfunction potentially driving targeted genome instability and mediated by NR2C/F proteins in ALT cells which probably underlie complexity of sarcomas genome. Understanding the ALT mechanism allows designing NR2C/F-targeted therapies in treatment of ALT tumors and therapies for patients treated with anti-telomerase drugs to prevent ALT appearance.

Many factors detrimental to healthy aging have been proposed including depression, stress, cognitive decline, and telomere shortening. Of specific interest are the genetic factors that may contribute to these factors and subsequently lead to accelerated telomere shortening and aging, namely the Bcl1, 5-HT, DRD2, and ApoE polymorphisms. We sought to: 1) further clarify the role of depression, stress tolerance, and cognitive decline in aging by examining the effect of associated polymorphisms (Bcl1, 5-HT, DRD2, and ApoE) on telomere length in two samples of older adults and 2) determine the difference in absolute telomere length between the two groups. We examined two samples of older adults: participants in a competitive, athletic event (N=220; mean age=66.8 years) and a sample of community-dwelling older adults (N=208; mean age=69.1 years). Participants completed a questionnaire with demographic information and provided a saliva sample. The Bcl1, 5-HT, DRD2, and ApoE polymorphisms were determined using PCR and Taqman assays. Telomere length was determined using qPCR analysis. The community-dwelling group had significantly shorter telomere lengths than the athletic group (t=-4.82, p< .0001). Additionally, for males in the athletic group, the L/S genotype of the 5-HT polymorphism was associated with longer telomere length. In males in the community-dwelling group, the GC genotype of the Bcl1 polymorphism was associated with shorter telomere length. In females in the athletic group, the GC and GG genotypes of the Bcl1 polymorphism were associated with shorter telomere length with the opposite being true for females in the community-dwelling group: the GC genotype of the Bcl1 polymorphism predicted longer telomere length. Exercising nearly everyday and the length of exercise were associated with telomere length in both groups. Our results indicate that competitive athletic activity in older age is associated with increased telomere length, longer periods of exercise at one time may contribute to longer telomere length, and the Bcl1 and 5-HT polymorphisms are associated with telomere length in older adults.

Les extrémités des chromosomes portent des structures nommées télomères, nécessaires à la survie des cellules. La sénescence réplicative induite par l’altération des télomères bloque les proliférations cellulaires excessives. Cependant, certaines cellules échappent à ce contrôle et deviennent immortelles. Je me suis intéressée aux mécanismes permettant de reconstituer des télomères fonctionnels par recombinaison chez la levure. Le noyau est divisé en sous-compartiments plus ou moins permissifs pour la recombinaison. J’ai étudié comment la localisation des télomères dysfonctionnels aux pores nucléaires (NPC) conditionne leur réparation et la prolifération des cellules. J’ai montré que les lésions réplicatives au télomères sont relocalisées aux NPC ce qui favorise leur réparation par un mécanisme conservatif. J’ai aussi montré la présence aux NPC de cercles d’ADN télomérique qui pourraient servir de matrice pour allonger les télomères et sortir de la sénescence réplicative. / Chromosome ends are formed by structures called telomeres, which are necessary for genome integrity and cell survival. Upon aberrant proliferation, as in precancerous cells, telomere alterations blocks cell proliferation, a mechanism called replicative senescence. However, some cells escape this control and become immortals. Using budding yeast as model, my work aimed to understand the mechanisms that allow cells to reconstitute functional telomeres using homologous recombination. The nucleus is divided in sub-compartments that are differently permissive for recombination. I investigated how the localization of dysfunctional telomeres to the nuclear pore complex (NPC) determines their repair and favors cell proliferation. I showed that replicative lesions at telomeres relocate to the NPC allowing conservative repair by recombination. I further shed light on the presence at NPC of telomeric DNA circles that may serve as template for telomere elongation and thus escape from senescence.

The acquisition and maintenance of cell division potential are important characteristics of tumorigenesis. Human telomerase reverse transcriptase (TERT) and telomerase RNA (TR) can immortalize cells through telomere maintenance, and telomerase activity is one factor that contributes to the in vitro transformation of normal cells. In vitro and in vivo evidence suggest that telomerase maintains telomeres as a functional multimer. In addition, hTERT may possess telomere maintenance-independent functions. To examine the effects of hTERT loss upon an in vitro generated tumorigenic cell line we created a tumorigenic cell line from human embryonic kidney cells through expression of the SV40 early region, H-RasG12V and a Cre-mediated excisable hTERT. These immortalized cells exhibited robust anchorage-independent colony growth and tumor formation in immuno-deficient mice. Cre recombinase expression resulted in the excision of hTERT from the tumorigenic cell lines, restoring cell mortality. A return to immortality was conferred by the re-introduction of wild-type hTERT, but not with hTERT point mutations in the N-terminus (hTEN) and reverse transcriptase (RT) domains that impair in vitro telomere elongation activity. The onset of cell mortality was not immediate, and the hTERT-excised tumorigenic cells exhibited clonal variation in the anchorage-independent colony growth assay and upon tumor formation in immuno-deficient mice. We hypothesized that tumorigenic potential was not related strictly to hTERT presence, but rather telomere length and/or integrity. To investigate this possibility we maintained the tumorigenic cell lines in the continuous presence of hTERT to permit telomere elongation prior to hTERT excision; subsequently, after hTERT excision tumor formation persisted, thus demonstrating a dependence on telomere length and not hTERT presence per se. To investigate the functional multimerization of hTERT in vivo we tested if two defective hTERT polypeptides with mutations in the hTEN and RT domains could restore telomere elongation activity in vivo. Unfortunately, during the course of these experiments an unanticipated recombination event occurred that restored a catalytically active hTERT transgene. Further in vivo analysis of hTERT multimerization should be carefully designed, accounting for the selective survival advantage bestowed by wild-type hTERT. This study provides compelling evidence that hTERT does not possess telomere maintenance-independent functions.

Structure-specific recognition of nucleic acids is a promising method to reduce the size of the recognition unit required to achieve the necessary selectivity and binding affinity for small molecules. It has been demonstrated recently that G-quadruplex DNA structures can be targeted by organic cations in a structure-specific manner. Structural targets of quadruplexes include the planar end surfaces of the G-tetrad stacked columns as well as four grooves. The significant structural differences between quadruplex DNA and duplex DNA make quadruplex DNA a very attractive target for highly selective, structure-specific drug design. We have used a variety of biophysical techniques including circular dichroism, surface plasmon resonance, thermal melting and absorbance spectroscopy to investigate small molecules that can selectively bind to the ends of human telomeric DNA as well as the ends of the G-quadruplex structure formed by the purine-rich promoter region of the c-MYC oncogene. We have also screened a library of heterocyclic diamidines, and identified one that binds selectively in the grooves of human telomeric quadruplex DNA. This compound is an excellent starting point for the design of new anti-cancer and anti-parasitic compounds with high affinity and selectivity for human telomeric DNA.